ABSTRACT OBJECTIVE: To determine whether the endocan level may be related to the severity of spinal cord injury. BACKGROUND: Several biomarkers were evaluated for this purpose, but endocan has never been studied before. It is correlated to endothelial dysfunction and ischemia, which are the characteristics of spinal cord injury in most cases. MATERIAL AND METHODS: A total of 21 male Sprague-Dawley rats weighing 300-350 g were randomly divided into three groups. In Group I, only a laminectomy was performed; in Group II, a mild SCI was performed after laminectomy; and, in Group III, a severe SCI was performed after laminectomy. At 48 h after the injury, after neurological assessment by Tarlov method, all animals were euthanized. A 5 cc blood sample was drawn for biochemical analysis, and spinal cord tissues were removed for histopathological examination. RESULTS: The difference between Groups I and III was statistically signifi cant (p < 0.05). There was also a moderately positive correlation between the severity of SCI and the endocan level (r = 0.59, p < 0.05). CONCLUSION: The endocan level may be used as an indicator to determine prognosis after SCI (Tab. 1, Fig. 2, Ref. 24). Text in PDF www.elis.sk.
Introduction
Traumatic spinal cord injury (SCI) represents a delicate situation for both the patient and the physician. It may result in the loss of motor, sensory, and autonomic functions below the level of injury, which is devastating for the patient. The damage can result in a spectrum of outcomes from a complete recovery to partial or complete paraplegia, tetraplegia, or death. It was reported that 30.1 % of patients had incomplete tetraplegia, 25.6 % had complete paraplegia, 20.4 % had complete tetraplegia, and 18.4 % had incomplete paraplegia, and that the mortality rate was 17 % after trauma involving SCI (1, 2) . The level and the severity of the injury are the major determinants of the functional results. However, there is a limitation in determining the prognosis, especially in incomplete injuries.
Biomarkers may be valuable tools for assessing the severity of SCI and determining the prognosis. Several biomarkers were evaluated for this purpose, such as: neuron-specifi c enolase (NSE), S100 beta (S100b) protein, glial fi brillary acidic protein (GFAP), and others. However, currently, there is no confi rmed biomarker.
Endocan is a novel molecule produced by endothelial cells. It is a proteoglycan molecule that circulates freely in blood (3). Its overexpression has been shown in several disorders, such as sepsis and infl ammatory diseases (4) (5) (6) , and correlated to endothelial dysfunction and ischemia, which had a close relationship with SCI. The aim of this study, then, was to investigate whether the endocan level was related to the severity of SCI and whether it might be used as a prognostic biomarker.
Materials and methods
The experimental protocol was approved by the local ethics committee. A total of 21 male Sprague-Dawley rats weighing 300-350 g were included in this study and randomly divided into three groups. In Group I, only a laminectomy was performed (Sham); in Group II, a mild SCI was performed after laminectomy; and, in Group III, a severe SCI was performed after laminectomy.
All rats were kept under standard conditions at 20-22 °C, at appropriate humidity under a 12-hour light-dark cycle. They were allowed to freely access water and food. Anesthesia was induced by intraperitoneal injection of 10 mg/kg of xylazine (Alfazyne, Egevet, Izmir, Turkey) and 50 mg/kg of ketamine (Ketalar, Parke-Davis, Eczacibasi, Turkey). The rats were placed in the prone position, and their backs were shaved and cleaned with 10 % polyvidone iodine (Bathicon; Adeka, Samsun, Turkey). A midline skin incision was made between T7 and T12, paravertebral muscles were dissected, and a total laminectomy was performed under the microscope at the T10 level. After laminectomy, the surgical wound was closed without SCI in Group I. After the same procedure for approach to the spinal cord, a vascular clip (Vascu-Statt®; Scanlan, St.Paul,MN) with 20 g closing force was applied to the T10 level of the spinal cord in Group II, and then the wound was closed. A vascular clip (Vascu-Statt®; Scanlan, St. Paul, MN) with 40 g closing force was applied to the same level of the spinal cord in Group III, and then the wound was closed. We compressed the spinal cord for one min, which was suffi cient to cause mild to severe damage (7) (Fig. 1) . At 48 h after the injury, the neurological status of all animals was evaluated according to the Tarlov method (8) . All animals were allowed to move freely, and an observer assessed the following: 0 = paraplegic (absence of muscle tonus and contraction), 1 = poor motor function, 2 = motion present, but not able to stand, 3 = able to stand and walk, and 4 = full recovery. After neurological assessment, all animals were euthanized by decapitation under a deep anesthesia and necropsied according to the Virchow technique. A 5 cc blood sample was drawn for biochemical analysis, and spinal cord tissues were removed for histopathological examination. Blood samples were centrifuged at 1,500 rpm for 15 min to obtain serum, and serum samples were stored at -80 °C before analysis of the endocan levels by enzyme-linked immunosorbent assay (ELISA). The spinal cord tissues were fi xed in 10 % neutral-buffered formalin for 48 h immediately after removal. The tissue samples were processed following the routine protocol; they were dehydrated in ascending grades of ethanol (50 %, 70 %, 96 %, and 100 %), cleared in xylene, and then embedded in paraffi n. Paraffi n-embedded tissue samples were sectioned at 5 μm thickness by a rotary microtome (Leica RM2125; Leica, Nussloch, Germany). The slides were stained with hematoxylin and eosin (H&E) for histological examination (Lilli, 2008) . Finally, the slides were examined and photographed using a light microscope with an imaging system (DM2500/DFC295; Leica, Nussloch, Germany). The pathological fi ndings were evaluated and the prevalence of infl ammatory reaction (PIR), which indicated cellular damage, was scored according to the percentage of glial cell proliferation in the region of the tissue damage with 10x objective by a pathologist. If there was no proliferation, it was scored as 0; if there was proliferation, it was scored as followed: < 1 % = 1; 1-9 % = 2; 10-32 % = 3; 33-65 % = 4, and > 65 % = 5 (9) .
Statistical analysis
All data were analyzed using the SPSS 10.0 software package (SPSS Inc., Chicago, IL, USA). The Mann-Whitney U test was used to compare the descriptive statistical measurements (mean, standard deviation (SD), median, frequency, ratio, minimum, and maximum) and the two groups of parameters that did not show a normal distribution in the comparison of the quantitative data. One way analysis of variance (ANOVA) was applied to assess the differences among the groups. Pearson's correlation analysis was performed to determine the signifi cance of the correlation. Signifi cance was evaluated at p < 0.05.
Results
Neurological examinations were assessed 48 h after the surgery. All of the rats were capable of walking, and the differences among the Tarlov scores in the three groups were not statistically signifi cant (p > 0.05) (Tab. 1). 
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In the evaluated spinal cord tissues, there were no signifi cant histopathological differences in Group I, and the spinal cord tissues showed normal histological structures ( Fig. 2A) . In Group II, there was mild perineural vacuolation of the neurons of the motor nucleus, degeneration of some of the neurons with a pyknotic nucleus, and neuronal shrinkage and proliferation of the glial cells around the central canal and the posterior horn in the gray matter. Mild spongious appearance (degeneration of myelin sheath) was observed in the white matter of the medulla spinalis and mild congestion of blood vessels in the pia mater Figure 2B) . In Group III, common lesions in the spinal cord tissues were the following: severe perineural vacuolation of the neurons of the motor nucleus, degeneration and necrosis of most of the neurons with pyknotic nucleus, neuronal shrinkage, loss of the neurons and diffuse hemorrhage with the loss of gray matter, and proliferation of the glial cells around the central canal and the posterior horn. Severe spongious appearance (axonal demyelination) was observed in the white matter of the medulla spinalis, and there was mild congestion of blood vessels in the pia mater (Fig. 2C) . Mean IRSs were 0, 2.75, and 4.5 for Groups I, II, and III, respectively. Differences between IRSs were statistically signifi cant among the three groups (p < 0.05) (Tab. 1). These histopathological results indicated our achievement to produce spinal cord damage at different severities.
The mean endocan level was 6.11 pg/ml in Group I, 9.23 pg/ml in Group II, and 10.73 in Group III. Differences between Groups I and II, and Groups II and III were not statistically signifi cant (p>0.05), but the difference between Groups I and III was statistically signifi cant (p<0.05) (Tab. 1). There was also a moderate positive correlation between the severity of SCI and endocan level (r=0.59, p<0.05).
Discussion
We found that there was a statistically signifi cant difference between Groups I and III regarding endocan levels, although the rats had similar neurological examination scores. Furthermore, there was also a moderate positive correlation between the severity of SCI and endocan levels.
The most common mechanism of SCI in humans is a combination of acute impaction and persistent compression (10) . First, the vertebral fragments are propelled into the spinal canal and lead to contusion, resulting in a compression of the cord. This fi rst effect is called the primary injury. The secondary injury state starts after the primary injury. It is characterized by ischemic dysfunction, infl ammation, oxidative stress, and neuronal injury, and this period may last for weeks. Because this is the method, which most likely resembles the real SCI mechanism in humans, we used vascular clips for compression, which have different closure pressures, on a vertical plane to create SCI of different severities. In this method, at the beginning of the closure, a contusion is caused by the clip blades, which leads to disruption of the spinal cord and hemorrhage, and, after completely closing the blades, the compression phase starts, which leads to ischemia (7) .
Because of the absence of an effective therapy, the prognosis of SCI patients primarily depends on the severity of injury. Although it is obvious that complete injuries have a poor prognosis, it is not possible to estimate the prognosis for an incomplete injury. The neurological examination, MRI assessment, and electrophysiological examination may all offer insights into the severity of the SCI and prognosis, but they all have limitations. For example, neurological examination is not suitable for the patients, who have complicated extremity fractures or who are not cooperative. Spinal shock may also develop after the injury, which may result in the absence of refl exes. On the other hand, if the neurological examination is not possible, MRI may provide some prognostic information, but, if the patient has an uncomplicated injury with a stable neurological condition, MRI does not provide additional prognostic information. Another method that may be used as a prognostic factor, electrophysiological examination, is not indicated in the evaluation of cooperative patients with SCI. Because of these limitations, Middendorp et al. emphasized the importance of and the need to fi nd possible biomarkers for SCI (11).
Because they are objectively quantifi able, easy to apply, and able to provide unbiased results, it is logical that the biomarkers may be valuable tools for assessing the severity of SCI. Ma et al. presented the increase in serum concentration of S100 beta protein in rats after SCI. S100 beta protein is mostly found in glial cells, and there are studies indicating its increase after traumatic brain injury. Therefore, it was reasonable to hope that S100 beta protein increases in blood. As a result, they suggested that the concentration of S100 beta protein in serum might be used as an early diagnostic tool after SCI (12). Loy et al also noted the elevation of NSE and S100 beta protein levels after an acute experimental SCI, and they suggested that these two neural tissue-derived tools may be used to assess the damage to the spinal cord (13). Cao et al also suggested the elevations of NSE and S100 beta protein after SCI, not only in serum, but also in the cerebrospinal fl uid (CSF), and emphasized that they could be used as biomarkers for acute SCI (14) . Guez et al found signifi cantly increased concentrations of both GFAP and neurofi lament (NFL) in the CSF in six cases with spinal cord damage (15). Kwon et al. obtained CSF and blood samples from 27 patients with complete or incomplete SCI. They measured cytokines by using the cytokine array system and standard ELISA techniques. When they compared the neurological recovery with the level of these cytokines, they found that IL-6, IL-8, MCP-1, tau, S100b, and GFAP were elevated in parallel to the severity of the injury (16). Pouw et al. reviewed 18 studies concerning biomarkers related to SCI. They found that most of the studies were focused on S100 beta and NSE levels and that, although the results were promising, there are currently no validated biomarkers (17) . Next, we considered whether a novel endocan molecule might be a biomarker for the severity of SCI. This is a proteoglycan molecule, which is specifi c to the endothelial cells. Several studies showed that the endocan molecule was overexpressed in some cancers (18) (19) (20) (21) . There was a correlation determined between the involvement of endocan and angiogenesis. Furthermore, it was also indicated that endocan might play a role in endothelial dysfunction (22) (23) (24) . Sepsis and infl ammation are also associated with endothelial dysfunction, as well as vasodilation, edema, coagulopathy, ischemia, and organ failure. When considering the relationship between endocan and endothelial dysfunction, ischemia, and infl ammation, we thought that it might be a biomarker related to SCI. When considering the pathophysiology of the spinal damage, secondary injury is also characterized by ischemia and infl ammation.
On the other hand, our study had several limitations: there was a relatively short follow-up period, samples were not taken from CSF, and blood samples were taken only during sacrifi ce, rather than at different times after the trauma.
In conclusion, our study supports that the endocan level increases in parallel to the severity of SCI in incomplete injuries; therefore, it may be used as a prognostic biomarker in SCI for determining the severity of the injury. We believe that our results are an important contribution to literature considering the diffi culty and limitation in predicting prognosis in SCIs.
Learning points
When considering the pathophysiology of SCI, endocan might be a biomarker for severity and prognosis.
